Related Experiment Video
Updated: Jun 22, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
RANK, RANKL and osteoprotegerin in bone biology and disease.
H L Wright1, H S McCarthy, J Middleton
1ISTM, Medical School, Keele University at the Leopold Muller Arthritis Research Centre, RJAH Orthopaedic Hospital, Oswestry, Shropshire, SY10 7AG, UK. HelenL.smith@rjah.nhs.uk
This review updates knowledge on Receptor Activator of Nuclear factor Kappa-B (RANK), RANK Ligand (RANKL), and Osteoprotegerin (OPG). It details their roles in bone resorption and bone disease regulation.
Area of Science:
- Bone Biology
- Skeletal Physiology
- Pathophysiology
Background:
- The discovery of RANK, RANKL, and OPG in the late 1990s revealed their critical roles in skeletal maintenance.
- Their significant involvement in bone diseases was initially unexpected, highlighting a gap in understanding.
- Recent advancements have greatly expanded our knowledge of these key proteins and their regulatory mechanisms.
Purpose of the Study:
- To provide an updated overview of the latest research on RANK, RANKL, and OPG.
- To elucidate the intricate mechanisms controlling bone resorption in both normal physiological and pathological conditions.
- To consolidate current understanding of these proteins' regulation for researchers and clinicians.
Main Methods:
- Literature review of recent scientific publications.
- Synthesis of current data on RANK, RANKL, and OPG pathways.
- Analysis of regulatory mechanisms governing bone resorption.
Main Results:
- Detailed explanation of the RANK/RANKL/OPG signaling pathway.
- Insights into how dysregulation of these proteins contributes to various bone pathologies.
- Identification of key factors influencing the balance of bone resorption.
Conclusions:
- The RANK/RANKL/OPG system is central to bone homeostasis.
- Understanding the regulation of these proteins is crucial for developing therapies for bone diseases.
- Continued research is essential to further unravel the complexities of bone remodeling.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling and Repair
